DEVLIES PHARMA
ActiveSummary
DEVLIES PHARMA has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €149,857 and a net result of -€13,894. Equity remains stable across the filed financial years (±0.3% per year). Its solvency ranks better than 33% of 12,482 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
Directors
Directors
No directors read yet: 0 of 6 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.